Skip to content
Unrated Medical device recall · FDA · Published August 14, 2024

Innovasis TxHA PEEK IBF System Recall: Interfacing Issues with Implant Trial

Innovasis recalls specific spinal fusion implants due to interfacing issues between the implant trial and inserter, which could lead to improper device function during surgery.

🇺🇸 FDA recall #Z-3163-2024Medical deviceInnovasis ›
Take action

Contact the company

Recalling firmInnovasis, Inc614 E 3900 S · Salt Lake City, UT 84107-1902
✎ GovInfoNow plain-language explainer

What happened, in plain English

Innovasis is recalling certain spinal fusion implants (TxHA PEEK IBF System) because they may not interface correctly with the inserter during surgery. This could lead to improper fusion or complications if used without addressing the issue. Read more at govinfonow.com/recall/54234-innovasis-txha-peek-ibf-system-recall-interfacing-issues-with-implant.

Source Summary by GovInfoNow · govinfonow.com/recall/54234-innovasis-txha-peek-ibf-system-recall-interfacing-issues-with-implant · Updated August 19, 2026 · FDA enforcement record: FDA #Z-3163-2024

Cite this page

“Innovasis TxHA PEEK IBF System Recall: Interfacing Issues with Implant Trial.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/54234-innovasis-txha-peek-ibf-system-recall-interfacing-issues-with-implant. Based on FDA recall #Z-3163-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-3163-2024%22&limit=1).

Why it’s dangerous

The recall is due to potential interfacing issues between the implant trial and the inserter device during spinal fusion surgery. This could result in improper device function, which might lead to complications like failed fusion or unintended movement of the spinal segment.

Who’s affected

Physicians trained in orthopedic surgery who use these spinal fusion implants for intervertebral body fusion procedures are most at risk. The affected devices are specific implant trials sold to hospitals and surgical sites.

How to tell if you have this one

Check for the specific implant trial models listed in the recall: LS-397-0705 to LS-433-1112 with serial numbers 001-027. These devices have unique UDI-DI codes and dimensions as described in the recall notice.

  • Brand
    Innovasis
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Device Details

    Review the UDI-DI code and serial numbers on your implant trial to confirm if it matches the recalled models listed in the notice.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 9 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: named in the noticeIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: nationwideILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: named in the noticeSDIowa: nationwideIAIndiana: nationwideINOhio: nationwideOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: named in the noticeCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: nationwideMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: named in the noticeALGeorgia: nationwideGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “U.S. Nationwide distribution in the states of AL, CA, CO, FL, ID, MI, SD, TX and WI.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, California, Colorado, Florida, Idaho, Michigan, South Dakota, Texas, Wisconsin.

Recall timeline

FDA published this recall 42 days after the firm started it.

1. Firm started the recall: Aug 14, 202412. FDA classified it Class II: Sep 17, 202423. Published in FDA’s Enforcement Report: Sep 25, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-3163-2024 (August 14, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-3163-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA